Cold & Cough Remedies - Benelux

  • Benelux
  • In Benelux, the revenue in the Cold & Cough Remedies market market for 2024 stands at US$0.48bn.
  • This market is projected to have an annual growth rate of 4.56% (CAGR 2024-2029).
  • When compared globally, the in the United States generates the highest revenue, reaching a total of US$11,190.00m in 2024.
  • In terms of per person revenues, the figure for 2024 amounts to US$16.06.
  • Despite a growing trend towards natural remedies, the Benelux market for cold & cough remedies still heavily relies on traditional pharmaceutical options.

Key regions: United States, Japan, Australia, United Kingdom, China

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Cold & Cough Remedies market in Benelux has been experiencing steady growth in recent years. Customer preferences for over-the-counter remedies and the availability of a wide range of products have contributed to this growth. Additionally, several trends in the market have further fueled its development. Customer preferences in the Benelux region have shifted towards self-medication and the use of over-the-counter remedies for cold and cough symptoms. This preference is driven by convenience and the desire for immediate relief. Consumers in Benelux appreciate the accessibility and affordability of these remedies, as they can be easily purchased without a prescription. Furthermore, the availability of a wide range of products allows customers to choose remedies that best suit their specific needs and preferences.Trends in the market have also played a significant role in the development of the Cold & Cough Remedies market in Benelux. One notable trend is the increasing demand for natural and herbal remedies. Consumers are becoming more conscious of the ingredients in the products they use and are seeking alternatives to traditional pharmaceutical remedies. This trend has led to the introduction of a variety of natural and herbal cold and cough remedies in the market. Manufacturers are capitalizing on this trend by developing innovative products that cater to this growing consumer demand.Another trend in the market is the rise of online retail channels. E-commerce platforms have become increasingly popular in Benelux, providing consumers with a convenient and efficient way to purchase cold and cough remedies. Online retailers offer a wide range of products, competitive prices, and the convenience of doorstep delivery. This trend has significantly contributed to the growth of the market, as it appeals to consumers who prefer the convenience of online shopping.Local special circumstances in Benelux have also influenced the development of the Cold & Cough Remedies market. The region's high population density and urbanization have created a conducive environment for the growth of the market. The availability of pharmacies and convenience stores in close proximity to consumers ensures easy access to cold and cough remedies. Additionally, the region's healthcare system, which emphasizes self-care and self-medication, further supports the growth of the market.Underlying macroeconomic factors have also played a role in the development of the Cold & Cough Remedies market in Benelux. The region's stable economy and high disposable income levels have enabled consumers to afford over-the-counter remedies. Moreover, the increasing prevalence of cold and cough symptoms, particularly during the winter months, has created a consistent demand for these remedies.In conclusion, the Cold & Cough Remedies market in Benelux is developing due to customer preferences for over-the-counter remedies, the availability of a wide range of products, and several market trends. The region's local special circumstances, such as high population density and urbanization, further support the growth of the market. Additionally, underlying macroeconomic factors, such as a stable economy and high disposable income levels, contribute to the development of the market.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Overview

  • Revenue
  • Analyst Opinion
  • Key Players
  • Sales Channels
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)